Tue.Oct 15, 2024

article thumbnail

GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV

Fierce Pharma

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting Moderna in a pair of lawsuits alleging the Massachusetts-ba | GSK is targeting Moderna in a pair of lawsuits claiming the mRNA specialist violated multiple patents with its vaccines Spikevax and mRESVIA. In the complaints, GSK says it hopes to recover a “reasonable royalty” tied to Moderna’s vaccine sales, plus damages.

Sales 326
article thumbnail

AlphaFold’s Nobel Prize is ‘the dawn of a new era’ in mapping drug development potential

PharmaVoice

A Nobel Prize in chemistry for Google’s DeepMind protein-structure mapping is the tip of the iceberg for advances in drug discovery and development.

116
116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Jazz's almost-withdrawn lung cancer drug Zepzelca extends life on top of Roche's Tecentriq

Fierce Pharma

Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it could prolong patients’ lives in extensive-stage small cell lung cancer (ES- | Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it could prolong patients’ lives in extensive-stage small cell lung cancer.

article thumbnail

On Heels of Positive Parkinson’s Gene Therapy Data, MeiraGTx Looks Ahead to Pivotal Test

MedCity News

In addition to meeting the main safety and tolerability goal, MieraGTx Holdings’ gene therapy for Parkinson’s disease also showed signs of efficacy. The one-time treatment is intended to reprogram dysfunctional brain circuits. The post On Heels of Positive Parkinson’s Gene Therapy Data, MeiraGTx Looks Ahead to Pivotal Test appeared first on MedCity News.

Safety 112
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Johnson & Johnson eases initial Stelara blows with strong Darzalex, Carvykti growth

Fierce Pharma

Johnson & Johnson's immunology superstar Stelara and oncology blockbuster Darzalex have long been among the company's top revenue contributors. | The company picked up a record $3 billion in quarterly sales for its multiple myeloma powerhouse Darzalex as it grooms Tremfya to take on Stelara's market dominance.

Sales 253
article thumbnail

Finding the Cure for Data Interoperability in Value-Based Care

MedCity News

Payers and providers alike are struggling with data interoperability. It’s clear that a more unified approach to data management is essential for payers to effectively navigate the complexities of value-based care. The post Finding the Cure for Data Interoperability in Value-Based Care appeared first on MedCity News.

More Trending

article thumbnail

Inaccurate Provider Data Hinders Value-based Care, But it Doesn’t Have To

MedCity News

Healthcare is a data-driven industry, but it’s held together by incompatible, siloed data systems. Providers and payers need the ability to exchange data and update directories in real time; otherwise, they cannot ensure patients will access the high-quality care they deserve. The post Inaccurate Provider Data Hinders Value-based Care, But it Doesn’t Have To appeared first on MedCity News.

article thumbnail

Lundbeck drops in on epilepsy drug with $2.6bn Longboard bid

pharmaphorum

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster.The Danish drugmaker has offered $60 per share for California biotech Longboard, with the main asset in the deal bexicaserin, an oral, centrally acting serotonin 5-HT 2C receptor super-agonist in late-stage testing for seizures associated with rare forms of epilepsy.

article thumbnail

Headspace Introduces AI Companion To Support Patients Through ‘Ebbs and Flows’ of Life

MedCity News

Headspace recently introduced Ebb, an empathetic AI companion. It helps users reflect and sort through their emotions, and provides recommendations for mental health content. The post Headspace Introduces AI Companion To Support Patients Through ‘Ebbs and Flows’ of Life appeared first on MedCity News.

Patients 105
article thumbnail

US digital health spending set to increase, survey finds

pharmaphorum

Health plans, employers, and healthcare providers plan to increase their spending on digital health technologies in the next 12 months, says PHTI survey

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights

MedCity News

PurpleLab® stands out from others in this sector by providing its data analytics services to several different groups of users across healthcare and pharma companies. The post The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights appeared first on MedCity News.

article thumbnail

GITEX GLOBAL 2024: Huawei launches a series of industrial digital and intelligent transformation solutions, and flagship products

Pharmaceutical Technology

Huawei hosted GITEX's Industrial Digital and Intelligent Transformation Summit and launched joint solutions with partners for ten industries.

94
article thumbnail

Parakeet Health Flies Onto The Scene to Automate Healthcare Call Centers

MedCity News

Generative AI-powered voice platform Parakeet Health announced its launch and $3 million in seed funding. The startup seeks to automate many of the interactions that patients have with their doctor’s staff, such as scheduling appointments and answering billing questions. The post Parakeet Health Flies Onto The Scene to Automate Healthcare Call Centers appeared first on MedCity News.

article thumbnail

GSK turns its guns on Moderna in mRNA jab patent dispute

pharmaphorum

GSK has filed lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and RSV

107
107
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Lundbeck to acquire Longboard Pharmaceuticals for $2.6bn

Pharmaceutical Technology

Lundbeck is to acquire Longboard for $2.6bn equity value in a move set to enhance its capabilities within neuro-rare conditions.

article thumbnail

LEO launches chronic hand eczema drug in its first market

pharmaphorum

Germany is the first market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema

article thumbnail

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

PharmaVoice

Data readouts over the next six months could set expectations for how the highly lucrative market for weight loss therapies will look in the future.

article thumbnail

Celltrion unveils promising dose escalation results for subcutaneous infliximab

PharmaTimes

Study reveals potential new strategy for managing inflammatory bowel disease

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Chiesi Launches Biotech Center of Excellence in Parma, Italy

PharmaTech

The design of the center prioritizes integration of the entire supply chain, with the end goals of accelerating product development and autonomous production capacity in alignment with EU priorities.

59
article thumbnail

Assembly Required: Building Blocks in Biopharma

PharmExec

Highlighting two pieces beyond Pharm Exec's October headliners that draw interesting parallels when it comes to life sciences leadership and building teams and capability internally—whether new businesses or new brands.

article thumbnail

BioDuro-Sundia Bolsters Drug Discovery Services with New Center in Shanghai

PharmaTech

The global CRDMO said its clients would be able to expedite R&D processes, thereby reducing costs and potentially leading to accelerated discovery of new candidate therapies.

Leads 52
article thumbnail

Access Insights 2024: Playing the Chess Endgame: Healthcare Policies Targeting Drug Commercialization

Pharmaceutical Commerce

William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses breakout session and the impact of healthcare policies on manufacturing and commercialization.

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Maximize Operational Flexibility and Efficiency without Compromising Quality

PharmaTech

Amid surging drug shortages and costly launch delays, it’s crucial to enhance operational flexibility and efficiency without compromising quality. Discover how end-to- end integrated automation systems can streamline your processes, improve flexibility, reduce time-to-market, maximize revenue, and drive continuous improvement. Transform your pharmaceutical manufacturing processes today!

article thumbnail

Seeking Sustainable Solutions: Can Passion and Profit Coexist in Pharma ESG Efforts?

PharmExec

Industry leaders gather to discuss different ways life sciences organizations can champion their environmentally-conscious younger employees while combatting still-entrenched public mistrust.

Pharma 52
article thumbnail

Make Paperless Manufacturing a Reality for your Pharmaceutical Facility

PharmaTech

Revolutionize pharmaceutical manufacturing through paperless manufacturing. By eliminating paper-based processes, you can quickly centralize your data, reduce cost and time, minimize errors, and release products faster. Even the simplest “paper on glass” digital systems enable streamlined workflows and can ensure real-time data access and seamless communication.

article thumbnail

Pharma’s Cold Calling: CGT Space at a Critical Crossroads

PharmExec

As the overall industry pipeline of allogeneic T-cell therapies expands, the onus on manufacturers and their partners to adeptly manage the complex cryogenic logistics process intensifies.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Digitalisation propelling automated microbiology market growth to 2033

European Pharmaceutical Review

A report by MarketResearch.biz predicts that the global automated microbiology market will reach $16.2 billion by 2033. This sector will secure a CAGR of 9.3 percent between 2024 and 2033, the research, the research forecast. The global automated microbiology market is projected to experience “substantial growth” in 2024, driven by technological advancements and the increasing demand for efficient and accurate microbial testing.

article thumbnail

Balancing Personalized Marketing and Maintaining Data Privacy

PharmExec

In this part of her video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One and Pharmaceutical Executive Advisory Board Member discusses how pharmaceutical companies can effectively balance personalized marketing efforts with maintaining data privacy and ensuring patient trust.

article thumbnail

Biopharma Recap: Q3 2024

Zymewire

In our Q3 2024 biopharma recap, we dive into the latest trends in funding, clinical trial activity, and therapeutic focus areas across the industry. With updated data on regional funding shifts and insights into the evolving biopharma landscape, this report will help CROs and CDMOs refine their strategies as they prepare for 2025. You can visit this page to download all charts from this report.

article thumbnail

5 Secrets to Creating High-Impact Marketing Materials That Boost Pharma Brand Recall

eMediWrite

Creating marketing materials that truly connect with healthcare professionals (HCPs) and decision-makers in the congested pharmaceutical market can be difficult. Generic and boring content is often the cause of low brand recall. Here are 5 ways to address these issues and create materials with a strong effect that endure: Prioritize Clarity and Simplicity Data-heavy information and complicated medical content might be overwhelming for HCPs.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A